ClinVar Miner

Submissions for variant NM_000687.4(AHCY):c.257A>G (p.Asp86Gly)

gnomAD frequency: 0.00003  dbSNP: rs773162208
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000778630 SCV000914954 uncertain significance Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 2018-12-07 criteria provided, single submitter clinical testing The AHCY gene c.257A>G (p.Asp86Gly) variant is a missense variant that has been reported in two studies and found in one sibling-pair with AHCY deficiency in a compound heterozygous state with another missense variant (Vugrek et al. 2009; Grubbs et al. 2010). The p.Asp86Gly variant was inherited from the mother and the other missense variant (p.Arg49Cys) was inherited from the father. Control data are unavailable for this variant, which is reported at a frequency of 0.00008 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional evidence from expression of the p.Asp86Gly protein in E.coli showed reduced AHCY activity as measured by enzyme assays, and PAGE studies showed enzymatically inactive aggregates (Vugrek et al. 2009). Based on the evidence, the p.Asp86Gly variant is considered to be a variant of unknown significance but suspicious for pathogenicity for hypermethioninemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Ambry Genetics RCV001266439 SCV001444614 likely pathogenic Inborn genetic diseases 2018-11-21 criteria provided, single submitter clinical testing
Invitae RCV000778630 SCV003260688 pathogenic Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 2023-08-17 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 86 of the AHCY protein (p.Asp86Gly). This variant is present in population databases (rs773162208, gnomAD 0.006%). This missense change has been observed in individual(s) with S-adenosylhomocysteine hydrolase (AHCY) deficiency (PMID: 20852937). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 631872). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AHCY protein function. Experimental studies have shown that this missense change affects AHCY function (PMID: 19177456). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000778630 SCV004244390 not provided Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 2024-02-06 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.